Freudenberg Medical, a global developer and manufacturer of medical devices, components, and minimally invasive solutions for the medical device industry, announces three new technologies for medical device companies looking to accelerate time to market with a novel device, design, and process solution.
Introduced today at Transcatheter Cardiovascular Therapeutics Conference (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, are FlexSeal Introducer Sheath, FlexSeal Hemostasis Valve, and Composer Deflectable Catheter Handle Platform. These innovative devices are for companies looking to 1) accelerate time to market with a unique white label device, 2) access new design options for improving next generation catheter and delivery systems, or 3) reduce time when building new feature sets into products.
“Freudenberg Medical has been fine tuning these product solutions for over 18 months and we are extremely pleased with the results,“ said Mitch Moeller, CEO of Freudenberg Medical Minimally Invasive Solutions. “As a partner for innovation, we now offer our customers a growing family of finished device, design, and process solutions to help give them a competitive edge in development.“
FlexSeal Introducer Sheath with Hydrophilic Coating enables support access for large bore catheter procedures. FlexSeal Hemostasis Valve greatly improves hemostasis performance when integrated into next generation catheter or delivery systems. Composer Deflectable Catheter Handle Platform offers customers a commercialization ready, modularized, and versatile design technology that can help reduce project lead times and costs while adding next generation features into product lines that utilize catheters, introducer sheaths, and delivery systems.
Learn more about our innovative new offerings and determine how you can put Freudenberg Medical to work for your organization.